Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-21

Clinical Trial Update: Botulin-A Toxin Instillations and Overactive Bladder [Phase 1, Phase 2]

View source ↗

Summary

A Mayo Clinic-sponsored Phase 1/2 trial evaluated botulinum toxin type A instillations for overactive bladder/detrusor overactivity; results from the completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Mayo Clinic | Conditions: Overactive Bladder, Detrusor Instability | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-21